Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Dr. Hite is a pulmonologist in the Department of Critical Care at Cleveland Clinic. Prior to his arrival in 2013, he was Professor of Medicine and Chief of the Section on Pulmonary, Critical Care, Allergy and Immunologic Diseases at Wake Forest University School of Medicine.
In addition to his role as an intensivist, Dr. Hite has actively engaged in clinical and basic science research. He has served as a principal investigator on numerous clinical trials in critial care including his role as the principal investigator for the Wake Forest clinical center of the prestigious National Institutes of Health (NIH)-sponsored ARDS Network since 2000. At the Cleveland Clinic, he now serves in a similar role including the role of principal investigator for the NIH Prevention and Early Treatment of Acute Lung Injury (PETAL) Clinical Trials Network, the successor to ARDSNet. Through its inclusion in PETAL, the Cleveland Clinic has entered its third decade of NIH network participation in ARDS research since the inception of ARDSNet in 1994. Dr. Hite also holds a joint appointment at the Cleveland Clinic Lerner Research Institute, where he maintains a laboratory focused on mechanisms of acute lung injury, including phospholipase up-regulation, surfactant dysfunction and surfactant replacement therapy. He has contributed to over 50 original research articles and has written numerous scholarly reviews and book chapters.
Dr. Hite currently serves as the chair of the Program Committee for the ATS Critical Care Assembly. He serves on the editorial board and as an ad hoc reviewer for multiple respiratory and critical care journals, and has served as chair and member for multiple DSMB and review groups for currently ongoing NIH and industry sponsored clinical trials. He is the recipient of the Bryant Kendrick Award from the Hospice and Palliative Care Center of Winston-Salem and the Humanitarian Recognition Award from the CHEST Foundation for his work as a board member with the State Employee’s Credit Union Family House while still in Winston-Salem.
American College of Chest Physicians
American Thoracic Society
Society of Critical Care Medicine
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 5/19/2016, Dr. Hite has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.